Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Executive Team
    • Board of Directors
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media
  • Training Videos

Press Releases

Nov 27, 2018

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

Nov 6, 2018

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

Nov 1, 2018

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

Oct 29, 2018

Aethlon Medical to Present at the NYC Oncology Conference

Oct 16, 2018

Aethlon Medical to Present at the 2018 BIO Investor Forum

Sep 18, 2018

Aethlon Medical Receives National Cancer Institute Award

Aug 8, 2018

Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

Aug 2, 2018

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

Jul 23, 2018

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

Jun 25, 2018

Guy Cipriani Joins Aethlon Medical's Board of Directors

    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • ...21
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2023 Aethlon Medical, Inc. All Rights Reserved.